Oncology Information System Market Overview
The Oncology Information System Market is expanding as healthcare providers increasingly adopt digital solutions to improve cancer treatment planning, clinical workflows, patient management, and oncology data integration. Rising cancer prevalence, growing demand for personalized medicine, advances in artificial intelligence and machine learning, and the need for interoperable healthcare systems are key factors supporting market growth.
The global market was valued at USD 4.17 billion in 2024 and is expected to reach USD 4.52 billion in 2025 and USD 10 billion by 2035, representing an 8.3% CAGR during 2026–2035. North America remains the leading region, valued at USD 2.12 billion in 2024 and projected to reach USD 4.5 billion by 2035. Treatment Planning is a major application, increasing from USD 1.058 billion in 2024 to USD 2.909 billion by 2035, while software is expected to remain the dominant component.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/oncology-information-system-market
Key Players
Philips Healthcare, Accuray, Dilon Technologies, Mevion Medical Systems, Elekta, Mirada Medical, Brainlab, ViewRay, Innovative Imaging Technologies, RaySearch Laboratories, Varian Medical Systems, CIVCO Medical Solutions, Siemens Healthineers, GE Healthcare, and Carestream Health are among the key companies profiled in the market.
Market Drivers and Trends
The rising incidence of cancer worldwide is increasing the need for sophisticated information systems capable of managing growing volumes of patient data, treatment plans, clinical records, and outcomes.
Artificial intelligence, machine learning, and big-data analytics are transforming oncology information systems by supporting predictive analytics, treatment personalization, clinical decision-making, and improved patient management.
Growing investment in cancer research and development is generating demand for systems capable of supporting clinical trials, research data management, and increasingly complex treatment workflows.
Interoperability is becoming increasingly important as healthcare organizations seek seamless integration between oncology platforms, electronic health records, imaging systems, and other clinical technologies.
Market Segmentation
By Application: Treatment Planning, Clinical Workflow Management, Patient Management, and Data Management.
By Deployment: On-Premise, Cloud-Based, and Web-Based.
By End User: Hospitals, Ambulatory Surgical Centers, and Research Institutes.
By Component: Software, Services, and Hardware.
By Region: North America, Europe, South America, Asia Pacific, and Middle East & Africa.
Market Opportunities
AI-driven predictive analytics represents a significant opportunity for oncology information system providers seeking to improve treatment personalization and anticipate patient responses.
Integration with genomic medicine and precision-oncology platforms can enable more comprehensive patient insights and support individualized treatment strategies.
Cloud-based and interoperable systems offer opportunities to improve accessibility, scalability, collaboration, and data exchange across oncology care networks.
Telehealth and remote patient monitoring also create opportunities for oncology information systems to support consultations, follow-up care, and patient engagement beyond traditional clinical settings.
Recent Developments and Market Trends:
Siemens Healthineers announced a strategic partnership with Elekta in March 2025 to develop an integrated oncology information system platform focused on data sharing and workflow interoperability across radiotherapy clinics.
RaySearch Laboratories secured a major contract in December 2024 to deploy RayStation at a leading U.S. cancer center, integrating treatment planning with the center’s oncology information system.
Brainlab launched a cloud-based oncology information system module in January 2025 designed to interoperate with multiple radiotherapy systems and streamline clinical workflows.
Cloud adoption is gaining momentum as healthcare organizations seek scalable systems that can reduce infrastructure requirements while enabling easier access to oncology information.
The market is increasingly emphasizing interoperability, AI integration, personalized medicine, telemedicine, and patient engagement as healthcare providers pursue more connected and data-driven cancer care.
Reasons to Buy the Report:
The report provides detailed market forecasts through 2035, including market size, CAGR, regional performance, and major industry dynamics.
It offers segmentation analysis across applications, deployment models, end users, components, and geographic markets.
The study identifies key growth drivers such as cancer prevalence, AI adoption, healthcare digitization, data integration requirements, and personalized medicine.
It provides competitive intelligence on leading oncology technology and healthcare IT companies, including their market positioning and strategic developments.
The report helps stakeholders identify opportunities in AI-enabled oncology, cloud deployment, interoperability, precision medicine, telehealth, and patient engagement.
Future Outlook
The Oncology Information System Market is projected to grow from USD 4.52 billion in 2025 to USD 10 billion by 2035 at an 8.3% CAGR. North America is expected to maintain its leadership, while Asia Pacific is positioned to record the highest growth rate as healthcare investment, cancer prevalence, and adoption of advanced healthcare technologies increase.
Future market development will be shaped by AI-powered treatment optimization, cloud-based platforms, genomic data integration, interoperability standards, telehealth, and increasingly personalized cancer care. As healthcare providers seek more efficient and connected oncology workflows, information systems are expected to become an increasingly important component of modern cancer-care infrastructure.
➤➤Explore Our Latest Related Reports:
